Monday, October 01, 2018 11:40:33 AM
SEC Orders Hearings On Registration Suspension Or Revocation Against Intellect Neurosciences, Inc. For Failure To Make Required Periodic Filings
Sep 18 18
Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Intellect Neurosciences, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=32390485
Dr. CHAIN took tauc3 patent after positiv results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439699/
Funding Statement
This work was supported by a sponsored research agreement from Intellect Neurosciences INC (http://www.intellectns.com/). Intellect Neurosciences also provided the anti-TauC3 antibody. Intellect Neurosciences had no role in study design, data collection and analysis, or preparation of the manuscript. They did approve the manuscript to be published. The Massachusetts Alzheimer Disease Research Center Brain Bank provided tissue samples (P50AG005134).
No announcement from ILNS!
TAUC3 patent and Dr. CHAIN private taubiologic corp.
Inventor G Chain Daniel Current Assignee Tau Bio-Logic Corp Original Assignee Intellect Neurosciences Inc
https://patents.google.com/patent/US20160122422
https://taubiologic.com/
Jesselson invested in ILNS and Cerespir
http://google.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=11151859-2047-23224&type=sect&TabIndex=2&companyid=685048&ppu=%252fdefault.aspx%253fsym%253dILNS
https://www.sec.gov/Archives/edgar/data/1683746/000168374616000001/xslFormDX01/primary_doc.xml
Reason?
https://www.sec.gov/Archives/edgar/data/1337905/000114420413027571/v344594_ex99-1.htm
http://google.brand.edgar-online.com/?sym=ILNS
SEC INVESTIGATION
Google: foia ibl intellect neurosciences sec
Things that are equal to the same thing are also equal to one another (Transitive property of equality). If equals are added to equals, then the wholes are equal. If equals are subtracted from equals, then the remainders are equal. Things that coincide wi
Recent MGTI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 06:21:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/29/2023 05:15:26 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/22/2023 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:30:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/13/2023 04:29:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:27:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 09:15:13 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM